We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Microbiologics Acquires Phthisis Diagnostics, New Direction Exhibited at Current Meeting of the Association for Molecular Pathology

By LabMedica International staff writers
Posted on 11 Nov 2013
Print article
Phthisis Diagnostics (Charlottesville, VA, USA) has announced its acquisition by Microbiologics (St. Cloud, MN, USA) to establish Phthisis’ technology as the foundation for a new division at Microbiologics.

Pthisis’ patented “G-Sphere” molecular standards product line will be the foundation for Microbiologics’ launch into molecular products and for the new division it is forming. G-Sphere standards are synthetic genes that provide easy-to-use, safe, stable, consistent, and abundant controls for virtually any organism or molecular assay. Currently, Microbiologics produces an array of lyophilized microorganism products in convenient, ready-to-use formats for quality control of microbiological testing.

Crystal Icenhour, PhD, adjunct assistant professor of infectious diseases at Duke University Medical Center, and President and Chief Science Officer at Phthisis since 2006, along with her research team, created the new technology. She will serve as an advisor with Microbiologics during the adoption of Phthisis’ technology and development of their new division. “We introduced this product line about a year ago to provide much needed quality control standards to molecular laboratories. I am pleased that this longer established company will have the structure to take these products much further than our smaller company could have,” said Prof. Icenhour.

Brad Goskowicz, Microbiologics CEO, commented, “These innovative molecular standards will lay the foundation for Microbiologics to design and launch a broad collection of molecular products and custom services. It will expand our range of biomaterials to include viruses and other hard to grow microorganisms.”

Microbiologics is adding Brian Beck, PhD in bacteriology, to its senior management team as Vice President of Molecular Products and Services. Dr. Beck has spent the last ten years at ATCC in Virginia where he managed the Microbiology Collection and Associated BioServices. “I’m quite excited to extend what Microbiologics has done with their culture business and bring that same practical, user-friendly format to the molecular diagnostic business,” said Dr. Beck.

To commence their new initiative, Microbiologics is exhibiting at the Association for Molecular Pathology (AMP) annual meeting, November 14-16, 2013, Phoenix (Arizona, USA).

Related Links:

Phthisis Diagnostics
Microbiologics


Gold Member
Troponin T QC
Troponin T Quality Control
Automated Blood Typing System
IH-500 NEXT
New
Automatic Biochemistry Analyzer
Audmax 180 Evolution
New
Hepatitis B Virus Test
HBs Ab – ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.